11 Apr. 2019
ANTIBIOTIKADEBATTE: DRINGEND GESUCHT: NEUE ANTIBIOTIKA
Antibiotikaresistenzen greifen immer mehr um sich..... Der Bedarf an neuen Wirkstoffen ist gross See also the Berlin Conference on Novel Antimi...
11 Apr. 2019
WIRKSTOFFFORSCHUNG: RESISTENZBRECHER DRINGEND GESUCHT
Die Antibiotikaforschung in Mitteleuropa hat unverkennbar an Dynamik gewonnen.
11 Apr. 2019
FIGHTING AMR EFFICIENTLY
...."SMEs are the keystone to fuel the pipeline by providing new innovative compounds and technologies and conducting both early and clinical stage re...
11 Apr. 2019
THE LANCET INFECTIOUS DISEASES: MULTI-DRUG RESISTANT BACTERIA IN CHINA
Mapping the scale of mcr-1-mediated resistance in clinical settings
Recent Media Feeds
- Press Release - BioVersys hires new CDO, Dr. Glenn Dale
- Eurostars Funds IMPACT2 Press Release
- Dr. Gitzinger will be speaking at the UNCTAD/WHO event in Geneva, October 23rd, 2018 from 14:30-17:30 on Fostering investment in the development of new antibacterial treatments
- CARB-X welcomes UK Government and Bill & Melinda Gates Foundation as new partners
- BioVersys successfully closes Series A2 financing round
- October 20th, 2017; BioVersys and Marc Gitzinger were featured in the 3Sat news.
- BEAM Alliance fordert G20 Staaten zu mehr Unterstützung im Kampf gegen tödliche Superkeime auf
- Swiss biopharma BioVersys is collaborating with drug discovery and development CRO Aptuit on the discovery and development of new targets and drug candidates against Gram-negative bacteria, including drug-resistant strains. An existing BioVersys target will be included in the partnership.
- Press Release BEAM Alliance / Biocom AG
- Breaking through the Wall ... A Call for Concerted Action on AB Research and Development
